Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 57.15
-1.85 (-3.14%)
Apr 17, 2026, 11:55 AM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 45.43 billion as of April 16, 2026. Its market cap has increased by 573.02% in one year.
Market Cap
45.43B
Enterprise Value
44.32B
Revenue
1.53B
Ranking
n/a
PE Ratio
123.30
Stock Price
57.15
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 45.43B, an increase of 340.45%. That is a compound annual growth rate of 50.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 48.23B | 104.48% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 102.92B |
| RemeGen | 82.12B |
| 3SBio | 59.64B |
| Shanghai Henlius Biotech | 45.25B |
| Shanghai Junshi Biosciences | 43.42B |
| InnoCare Pharma | 30.28B |
| Shanghai Bao Pharmaceuticals | 29.99B |
| TransThera Sciences (Nanjing) | 28.01B |